Neurotrack
About Neurotrack
Neurotrack is a digital health company that provides a cognitive care enablement platform designed to assist healthcare providers in the early detection, diagnosis, and management of mild cognitive impairment (MCI) and dementias, including Alzheimer’s disease. Their platform offers clinically validated digital cognitive assessments, including a three-minute digital screening tool for annual wellness visits. These assessments leverage proprietary eye-tracking technology and digital task batteries to evaluate processing speed, executive function, and verbal memory.
The Neurotrack platform integrates adaptive decision logic to tailor assessments and care pathways in real-time, providing structured clinical documentation and patient-specific care plans for use in clinic, remote, and in-home settings. It is registered as an FDA Class II medical device and is supported by over 25 peer-reviewed publications and 11 patents. Beyond assessment, Neurotrack offers robust patient education and lifestyle-based brain health interventions, addressing modifiable risk factors such as diet, exercise, sleep, social engagement, stress management, and cognitive activity. The company aims to close the gap in cognitive care by providing tools that enhance diagnostic clarity and support personalized care planning, ultimately empowering providers to act earlier and with greater confidence in managing cognitive decline.
Focus Areas
Business Intelligence
| Key Investors | Khosla Ventures, Founders Fund, Social Capital, AME Cloud Ventures, iSeed Ventures, Rock Health, Dai-ichi Life, Sompo Holdings, Rethink Impact, Sozo Ventures, Alzheimer's Drug Discovery Foundation, AgeTech Collaborative from AARP, Alzheimer's Association, Matter, Gershon Capital, Altimeter Capital, Battery Ventures, Cocoa, Dragoneer Investment Group, Foundamental, Joe Kraus, Klossy, Ludlow Ventures, Hans Tung, Prototype Capital |
| Partnerships | Midi Health, Hannover Re, SOMPO Himawari Life Insurance |
| Technology | cloud-native, adaptive Smart Logic™ technology, computer vision algorithms, eye-tracking technology, EHR integration |
| FDA Clearances | 1 (Class II medical device registration) cleared products (estimated) |
What Physicians Need to Know
Neurotrack provides physicians with a workflow-embedded solution for cognitive care, offering clinically validated digital assessments that are sensitive enough to detect MCI earlier and more accurately than traditional methods. The platform's Smart Logicu2122 guides diagnosis and care planning, reducing the 'confidence gap' in cognitive care. The assessments are quick (as little as three minutes for the initial step), can be administered by staff, and generate instant, objective, and EHR-integrated documentation, saving time and streamlining workflows. This allows for more in-house cognitive care, potentially boosting patient satisfaction and practice revenue, as testing is reimbursable under existing CPT codes and Medicare Annual Wellness Visits. Neurotrack also offers educational resources and CME courses to help providers feel equipped to manage cognitive decline.
Neurotrack integrates directly into major EHR platforms, generating structured clinical documentation that automatically flows into the patient record. This includes assessment results, DSM-5 aligned documentation, and care planning outputs, ensuring data is available where and when providers need it. The integration is designed to work within existing infrastructure, not alongside it, facilitating straightforward adoption for clinical and operations teams.
What the Web Says
Neurotrack is a company focused on cognitive care, offering a platform with clinically validated assessments, adaptive technology, and care planning support to detect cognitive impairment earlier and more accurately. Their core product, the Imprint cognitive assessment, is a non-invasive, virtual reality-based test that measures eye movements to detect subtle changes in memory performance. While the company's mission to prevent Alzheimer's and use digital solutions for healthcare is praised, there are some concerns regarding financial transparency and the need for further validation of their programs.
Overall: MixedStrengths
- Non-invasive and accessible cognitive assessment method.
- Potential for early detection of cognitive decline.
- Personalized programs with actionable lifestyle interventions.
- Clinically validated assessments designed for early and accurate detection of MCI.
- Helps healthcare providers diagnose with confidence and create patient-specific care plans.
- Friendly and supportive work environment.
Limitations
- VR headset requirement can be a barrier for some users, especially older adults.
- Accuracy of the assessment requires further validation through large-scale studies.
- Effectiveness of personalized programs needs definitive proof.
- Not a diagnostic tool; low scores require further medical evaluation.
- Reliance on eye-tracking as a sole indicator can be limiting.
- Uncertainty in business and finance, with a lack of transparency to employees.
Based on reviews from: Indeed.com, YouTube, Reddit, Neurotrack.com
Last updated: 2026-09-10
Videos
News, demos, and interviews about Neurotrack.
Videos load interactively. If none appear, search YouTube for Neurotrack →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]